PureTech Health plc PRTC NASDAQ

PureTech Health plc (PRTC) reported total assets of $602.64M and total liabilities of $194.7M for fiscal year 2024, resulting in total equity of $407.93M.

The company held $367.31M in cash and short-term investments. Total debt stood at $22.36M, with net debt of $-258.28M. The Debt-to-Equity (D/E) ratio was 0.05 (conservative).

Current ratio is 9.33, indicating strong short-term liquidity. Interest coverage is -13.6x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (50/100) — Total assets $602.64M and equity $407.93M support the company's competitive scale
• VALUE (91/100) — Debt-to-Equity 0.05 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 72/100 with 4/7 criteria passed.

OPT

Opthea Limited

$3.41

+1.49%

MLYS

Mineralys Therapeutics, Inc.

$27.32

+0.59%

NUVB

Nuvation Bio Inc.

$4.85

+3.19%

JANX

Janux Therapeutics, Inc.

$15.24

+2.28%

ELYM

Eliem Therapeutics, Inc.

$5.11

-0.97%

RZLT

Rezolute, Inc.

$3.56

-1.36%

GRPH

Graphite Bio, Inc.

$3.18

-2.75%

MOLN

Molecular Partners AG

$4.14

-1.66%